Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39167

DNAJC1 Knockout HGC-27 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Stomach

  • Disease:

    Carcinoma

The DNAJC1 Knockout HGC-27 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of HGC-27 human gastric adenocarcinoma cells with targeted disruption of the DNAJC1 gene. DNAJC1 encodes an ER-resident J-domain co-chaperone that stimulates HSPA5 ATPase activity, facilitating protein folding and ER homeostasis. This knockout model is ideal for studying ER stress response in gastric cancer, as loss of DNAJC1 impairs chaperone function and may alter UPR signaling through factors such as IRE1, XBP1, and CHOP. Applications include western blotting, RT-qPCR, ER stress induction assays, and drug screening for ER stress modulators.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HGC-27

    Sex of Donor

    Unknown

    Age

    Unknown

    Derived From Site

    Metastatic; Lymph node

    Gene Name

    DNAJC1

    Gene Identifier

    NCBI Gene ID 64215

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC1 Knockout HGC-27 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HGC-27 human gastric adenocarcinoma cell line. This product provides a loss-of-function model through CRISPR/Cas9-mediated disruption of the DNAJC1 gene, enabling investigation of DNAJC1??s role in endoplasmic reticulum (ER) proteostasis and stress signaling. The polyclonal population retains genetic heterogeneity, offering a robust tool for studying gene function without the limitations of clonal selection.

HGC-27 cells are a well-characterized epithelial cell line originally isolated from the lymph node metastasis of a human gastric adenocarcinoma. These cells serve as an established in vitro model for gastric adenocarcinoma, exhibiting features relevant to metastatic gastric cancer biology. Their use in knockout studies facilitates the dissection of molecular mechanisms underlying gastric cancer progression and therapeutic resistance.

DNAJC1 encodes an ER-resident J-domain co-chaperone that directly stimulates the ATPase activity of HSPA5 (BiP), a central regulator of ER protein folding and the unfolded protein response (UPR). DNAJC1 interacts with HSPA5, the SEC61 translocon, ribosomes, and ER membrane proteins to facilitate co-translational import and folding. Upstream stress sensors??including IRE1, ATF6, and PERK??activate UPR signaling cascades that converge on transcription factors such as XBP1s, ATF4, and CHOP, while DNAJC1 acts as a key co-chaperone that modulates HSPA5 function under both basal and ER stress conditions. Loss of DNAJC1 disrupts this chaperone network, leading to impaired protein folding capacity and prolonged UPR activation.

In the context of HGC-27 gastric cancer cells, DNAJC1 knockout likely compromises the adaptive ER stress response, sensitizing cells to proteotoxic insults and potentially altering survival pathways crucial for tumor growth and metastasis. Given the heightened ER stress experienced by rapidly proliferating cancer cells, this knockout model enables the study of how DNAJC1-dependent chaperone activity influences gastric cancer cell fitness, migration, and invasion under normal and stressed conditions.

Researchers can employ this polyclonal knockout population to investigate ER stress response mechanisms in gastric cancer using assays such as western blotting for DNAJC1, HSPA5, and UPR markers (CHOP, XBP1s), RT-qPCR for UPR target genes, immunofluorescence for ER morphology, and ER stress induction with tunicamycin or thapsigargin. Additional applications include cell viability and apoptosis assays under ER stress, co-immunoprecipitation to confirm DNAJC1-HSPA5 interaction, proteostasis analysis, and migration/invasion studies. This model is ideally suited for drug screening to identify ER stress modulators and for deciphering the molecular interplay between chaperone networks and oncogenic signaling. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)